Citation | Sperandio, D; Aktoudianakis, V; Babaoglu, K; Chen, X; Elbel, K; Chin, G; Corkey, B; Du, J; Jiang, B; Kobayashi, T; Mackman, R; Martinez, R; Yang, H; Zablocki, J; Kusam, S; Jordan, K; Webb, H; Bates, JG; Lad, L; Mish, M; Niedziela-Majka, A; Metobo, S; Sapre, A; Hung, M; Jin, D; Fung, W; Kan, E; Eisenberg, G; Larson, N; Newby, ZER; Lansdon, E; Tay, C; Neve, RM; Shevick, SL; Breckenridge, DG Structure-guided discovery of a novel, potent, and orally bioavailable 3,5-dimethylisoxazole aryl-benzimidazole BET bromodomain inhibitor. Bioorg Med Chem27:457-469 (2019) [PubMed] Article |
---|
SMILES | Cc1noc(C)c1-c1cc(-c2c(C)noc2C)c2nc([nH]c2c1)C1CC1 |(10.45,-37.7,;8.98,-37.23,;8.5,-35.76,;6.96,-35.77,;6.49,-37.23,;5.03,-37.72,;7.75,-38.13,;7.75,-39.67,;9.09,-40.43,;9.09,-41.98,;10.43,-42.76,;10.43,-44.29,;9.18,-45.2,;11.89,-44.77,;12.79,-43.52,;11.89,-42.28,;12.36,-40.82,;7.75,-42.76,;7.44,-44.26,;5.91,-44.43,;5.28,-43.02,;6.42,-41.99,;6.42,-40.44,;5.14,-45.76,;3.82,-46.54,;5.15,-47.3,)| |